Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging

Area of Science:

• Aging research
• Cellular senescence
• Tumor suppressor pathways

Background:

• Tumor suppressors p16(INK4a) and p53 are linked to age-related stem cell decline.
• p53 plays a critical role in DNA damage response, inducing cell cycle arrest, senescence, or apoptosis.
• Accelerated aging models are crucial for understanding age-associated cellular dysfunction.

Purpose of the Study:

• To investigate the roles of senescence and apoptosis in an accelerated aging mouse model with enhanced p53 activity (p53(+/m) mice).
• To determine how increased p53 activity influences DNA damage responses, specifically the balance between senescence and apoptosis.

Main Methods:

• Utilized the p53(+/m) mouse model exhibiting accelerated aging and increased p53 activity.
• Assessed senescence markers (beta-galactosidase, p16(INK4a), p21) and apoptosis in aged tissues.
• Examined responses to ionizing radiation in lymphoid tissues of p53(+/m) and p53(+/+) mice.

Main Results:

• Aged p53(+/m) mice showed significantly higher percentages of senescent cells compared to controls.
• Despite enhanced p53 activity, p53(+/m) lymphoid tissues exhibited reduced apoptosis after irradiation.
• Irradiation induced prolonged senescence markers (p16(INK4a), p21) in p53(+/m) tissues, indicating a shift from apoptosis to senescence.

Conclusions:

• Enhanced p53 activity in p53(+/m) mice shifts the stress response away from apoptosis towards senescence.
• This shift may impair the clearance of damaged cells, contributing to accelerated aging phenotypes like tissue atrophy and reduced regeneration.
• Failure to eliminate senescent cells via apoptosis is a potential mechanism driving accelerated aging in this model.